Your session is about to expire
← Back to Search
Behavioral Intervention
Home-Based Eating Disorder Therapies for Anorexia Nervosa
N/A
Recruiting
Led By Andrea B Goldschmidt, Ph.D.
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Must not have
Associated physical illness that necessitates hospitalization.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing two types of home-based family therapy for teenagers with anorexia nervosa. It aims to see if involving families in therapy can help improve eating habits and emotional well-being. The study will measure how effective, acceptable, and practical these treatments are. Family-based treatment (FBT) has demonstrated efficacy for anorexia nervosa (AN) in youth.
Who is the study for?
This trial is for adolescents with anorexia or atypical anorexia who are medically stable enough to be treated outside of a hospital, living at home with caregivers willing to participate in treatment, and not currently using other psychological treatments for eating disorders. They must also have a steady dose if they're on psychotropic medication.
What is being tested?
The study compares two types of therapy delivered at home: Family-based treatment (FBT) and Integrative family therapy. It aims to see which is more effective when given in the patient's own environment by assessing weight changes, eating behaviors, and how well families can apply what they learn.
What are the potential side effects?
Since this trial involves psychological treatments rather than medications, traditional side effects like you might see with drugs aren't expected. However, participants may experience emotional distress or discomfort as part of the therapeutic process.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a physical illness that requires me to be hospitalized.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Body mass index percentile
Eating Disorder Examination
Secondary study objectives
Abbreviated Acceptability Rating Profile
Acceptability, Appropriateness, and Feasibility of Intervention Measure
Attendance
+7 moreOther study objectives
Child & Adolescent Symptom Inventory (CASI)
Child Depression Inventory (CDI)
Difficulties in Emotion Regulation Scale (DERS-18)
+9 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Family-based treatmentExperimental Treatment1 Intervention
Families will complete 2-6 hours of therapy per week for 10 - 32 weeks, on average, determined by clinical need in conjunction with insurance specifications related to coverage of home-based care
Group II: Integrative family therapyActive Control1 Intervention
Families will complete 2-6 hours of therapy per week for 10 - 32 weeks, on average, determined by clinical need in conjunction with insurance specifications related to coverage of home-based care
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Family-Based Treatment (FBT) enhances caregiver involvement and self-efficacy, empowering families to support patients in normalizing eating patterns and achieving a healthy weight. Integrated Family Therapy (IFT) combines family dynamics and individual therapy to address relational and personal factors contributing to the disorder, reducing adolescent distress and improving treatment outcomes.
These approaches are crucial as they leverage the patient's support system, making treatment more holistic and potentially more effective.
Family in pediatric obesity management: a literature review.
Family in pediatric obesity management: a literature review.
Find a Location
Who is running the clinical trial?
Rhode Island CollegeOTHER
1 Previous Clinical Trials
LifespanOTHER
40 Previous Clinical Trials
41,028 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,905 Total Patients Enrolled
54 Trials studying Eating Disorders
23,507 Patients Enrolled for Eating Disorders
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- A participant has a condition that makes it difficult for them to take part in the study due to developmental delays.I live at home with caregivers ready to participate in my treatment.I am stable on my mental health medication and meet all other trial requirements.You have been diagnosed with an eating disorder called "anorexia nervosa" or "atypical anorexia nervosa" by a doctor using specific criteria from the DSM-5.I have a physical illness that requires me to be hospitalized.You have had a follow-up appointment.You have a severe mental illness that requires hospitalization, such as psychosis.You are currently addicted to drugs or alcohol.I have a condition like diabetes or am pregnant, affecting my eating or weight.
Research Study Groups:
This trial has the following groups:- Group 1: Family-based treatment
- Group 2: Integrative family therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger